Clinical Trial Update: Modafinil in Opioid Induced Sedation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating modafinil for opioid-induced sedation in cancer patients has been terminated. No efficacy results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Pain

Drugs mentioned

• Modafinil (modafinil)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Cancer, Pain | Phase 3 | Status: TERMINATED